These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 34480505)

  • 1. Clinical signs, duodenal histopathological grades, and serum high-mobility group box 1 concentrations in dogs with inflammatory bowel disease.
    Lee JH; Kim HS; Lee D; Yun T; Koo Y; Chae Y; Kang JH; Kang BT; Yang MP; Kim H
    J Vet Intern Med; 2021 Sep; 35(5):2205-2214. PubMed ID: 34480505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serologic and fecal markers to predict response to induction therapy in dogs with idiopathic inflammatory bowel disease.
    Otoni CC; Heilmann RM; García-Sancho M; Sainz A; Ackermann MR; Suchodolski JS; Steiner JM; Jergens AE
    J Vet Intern Med; 2018 May; 32(3):999-1008. PubMed ID: 29624721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of disease severity and outcome of dietary, antibiotic, and immunosuppressive interventions by use of the canine IBD activity index in 21 dogs with chronic inflammatory bowel disease].
    Münster M; Hörauf A; Bilzer T
    Berl Munch Tierarztl Wochenschr; 2006; 119(11-12):493-505. PubMed ID: 17172138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of serum C-reactive protein and high mobility group box 1 concentrations in 22 dogs with acute pancreatitis: a pilot study.
    Kim H; Kim HJ; Kang JH; Kang BT; Yang MP
    Vet Q; 2019 Dec; 39(1):122-130. PubMed ID: 31401946
    [No Abstract]   [Full Text] [Related]  

  • 5. A scoring index for disease activity in canine inflammatory bowel disease.
    Jergens AE; Schreiner CA; Frank DE; Niyo Y; Ahrens FE; Eckersall PD; Benson TJ; Evans R
    J Vet Intern Med; 2003; 17(3):291-7. PubMed ID: 12774968
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between fecal S100A12 concentration and histologic, endoscopic, and clinical disease severity in dogs with idiopathic inflammatory bowel disease.
    Heilmann RM; Grellet A; Allenspach K; Lecoindre P; Day MJ; Priestnall SL; Toresson L; Procoli F; Grützner N; Suchodolski JS; Steiner JM
    Vet Immunol Immunopathol; 2014 Apr; 158(3-4):156-66. PubMed ID: 24518653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of oral prednisone and prednisone combined with metronidazole for induction therapy of canine inflammatory bowel disease: a randomized-controlled trial.
    Jergens AE; Crandell J; Morrison JA; Deitz K; Pressel M; Ackermann M; Suchodolski JS; Steiner JM; Evans R
    J Vet Intern Med; 2010; 24(2):269-77. PubMed ID: 20051005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum calprotectin concentrations in dogs with idiopathic inflammatory bowel disease.
    Heilmann RM; Jergens AE; Ackermann MR; Barr JW; Suchodolski JS; Steiner JM
    Am J Vet Res; 2012 Dec; 73(12):1900-7. PubMed ID: 23176415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Duodenal and colonic mucosal S100A8/A9 (calprotectin) expression is increased and correlates with the severity of select histologic lesions in dogs with chronic inflammatory enteropathy.
    Nestler J; Syrjä P; Kilpinen S; Moniz CA; Spillmann T; Hanifeh M; Heilmann RM
    BMC Vet Res; 2024 Sep; 20(1):393. PubMed ID: 39238011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma amino acid profiles in dogs with inflammatory bowel disease.
    Tamura Y; Ohta H; Kagawa Y; Osuga T; Morishita K; Sasaki N; Takiguchi M
    J Vet Intern Med; 2019 Jul; 33(4):1602-1607. PubMed ID: 31111561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systemic levels of the anti-inflammatory decoy receptor soluble RAGE (receptor for advanced glycation end products) are decreased in dogs with inflammatory bowel disease.
    Heilmann RM; Otoni CC; Jergens AE; Grützner N; Suchodolski JS; Steiner JM
    Vet Immunol Immunopathol; 2014 Oct; 161(3-4):184-92. PubMed ID: 25183017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Correlating Gastrointestinal Histopathologic Changes to Clinical Disease Activity in Dogs With Idiopathic Inflammatory Bowel Disease.
    Allenspach KA; Mochel JP; Du Y; Priestnall SL; Moore F; Slayter M; Rodrigues A; Ackermann M; Krockenberger M; Mansell J; ; Luckschander N; Wang C; Suchodolski J; Berghoff N; Jergens AE
    Vet Pathol; 2019 May; 56(3):435-443. PubMed ID: 30563436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Urinary leukotriene E4 concentrations as a potential marker of inflammation in dogs with inflammatory bowel disease.
    Im Hof M; Schnyder M; Hartnack S; Stanke-Labesque F; Luckschander N; Burgener IA
    J Vet Intern Med; 2012; 26(2):269-74. PubMed ID: 22268894
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased concentrations of C-reactive protein but not high-mobility group box 1 in dogs with naturally occurring sepsis.
    Karlsson I; Wernersson S; Ambrosen A; Kindahl H; Södersten F; Wang L; Hagman R
    Vet Immunol Immunopathol; 2013 Nov; 156(1-2):64-72. PubMed ID: 24120445
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rifaximin is an effective alternative to metronidazole for the treatment of chronic enteropathy in dogs: a randomised trial.
    Menozzi A; Dall'Aglio M; Quintavalla F; Dallavalle L; Meucci V; Bertini S
    BMC Vet Res; 2016 Oct; 12(1):217. PubMed ID: 27716258
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma high-mobility group box 1 (HMGB1) in dogs with various diseases: comparison with C-reactive protein.
    Ishida A; Ohno K; Fukushima K; Nakashima K; Takahashi M; Goto-Koshino Y; Fujino Y; Tsujimoto H
    J Vet Med Sci; 2011 Sep; 73(9):1127-32. PubMed ID: 21558736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perinuclear antineutrophilic cytoplasmic antibody and response to treatment in diarrheic dogs with food responsive disease or inflammatory bowel disease.
    Luckschander N; Allenspach K; Hall J; Seibold F; Gröne A; Doherr MG; Gaschen F
    J Vet Intern Med; 2006; 20(2):221-7. PubMed ID: 16594575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum 25-hydroxyvitamin D and C-reactive protein and plasma von Willebrand concentrations in 23 dogs with chronic hepatopathies.
    Ambrosini YM; Piedra-Mora C; Jennings S; Webster CRL
    J Vet Intern Med; 2022 May; 36(3):966-975. PubMed ID: 35420222
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-2/caspase 3 mucosal imbalance favors T cell resistance to apoptosis in dogs with inflammatory bowel disease.
    Jergens A; Young J; Moore D; Wang C; Hostetter J; Augustine L; Allenspach K; Schmitz S; Mosher C
    Vet Immunol Immunopathol; 2014 Apr; 158(3-4):167-74. PubMed ID: 24495616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oral chondroitin sulfate and prebiotics for the treatment of canine Inflammatory Bowel Disease: a randomized, controlled clinical trial.
    Segarra S; Martínez-Subiela S; Cerdà-Cuéllar M; Martínez-Puig D; Muñoz-Prieto A; Rodríguez-Franco F; Rodríguez-Bertos A; Allenspach K; Velasco A; Cerón J
    BMC Vet Res; 2016 Mar; 12():49. PubMed ID: 26965834
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.